http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314080-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e856f3e64ff822e20578d6353252096b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_643aaec8eca1998737e149a69bafc4c5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
| filingDate | 2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_994e0cbdc8d78f71c01e2e884ea047c4 |
| publicationDate | 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8314080-B2 |
| titleOfInvention | Method of treating type I diabetes |
| abstract | The method of treating type I diabetes includes the treatment of diabetic patients with choline in order to control the patient's lipid profile. The treatment method includes the step of administering to the patient a therapeutically effective dosage of choline or a pharmaceutically acceptable salt thereof. In human patients, the effective dosage of choline is preferably approximately 10 mg., delivered daily. Although the choline may be injected in solution, it is preferably delivered orally to the patient. |
| priorityDate | 2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.